HTT and Huntington disease: Our study elucidates the molecular mechanism responsible for BACHD-SD mice ameliorated phenotype and underscores a critical need to identify enzymes responsible for regulating HTT phosphorylation to exploit their potential as therapeutic Huntington’s disease targets.